MBX Biosciences, Inc. Common Stock Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold64K60K100K00000
Gross Profit-64K-60K-100K00000
R&D Expenses18.5M19.8M19.3M17.7M22.4M15.2M16.7M14.4M
Operating Expenses27.3M25.8M23.9M21.8M26.5M18.6M19.6M16.7M
Operating Income-27.3M-25.8M-23.9M-21.8M-26.5M-18.6M-19.6M-16.7M
Other Income / Gains3.7M3.7M2.3M2.4M2.6M3.0M1.5M801K
Net Income-23.5M-22.1M-21.6M-19.4M-23.9M-15.6M-18.1M-15.9M
EPS (Diluted)-0.50-0.49-0.63-0.58-0.71-0.47-0.54-0.48
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses8.8M6.0M4.7M4.1M4.1M3.4M2.9M2.3M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses8.8M6.0M4.7M4.1M4.1M3.4M2.9M2.3M
Other Expenses00000000
Cost And Expenses27.3M25.8M23.9M21.8M26.5M18.6M19.6M16.7M
Interest Income3.7M-7.4M2.3M2.4M2.6M3.0M1.5M801K
Interest Expense00000000
Depreciation And Amortization64K60K50K61K77K58K75K63K
Ebitda-23.5M-22.0M-21.6M-19.4M-23.8M-15.5M-18.1M-15.8M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-23.5M-22.1M-21.6M-19.4M-23.9M-15.6M-18.1M-15.9M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-0.50-0.49-0.63-0.58-0.71-0.47-0.54-0.48
Weighted Average Shs Out46.6M36.5M34.2M33.4M33.4M33.4M33.4M33.4M
Weighted Average Shs Out Dil46.6M36.5M34.2M33.4M33.4M33.4M33.4M33.4M